Philips rises after beating adjusted EBITA estimates

By Reuters News

** Shares in Philips PHG.AS are up 4.5%, topping the main Amsterdam AEX .AAX index, after the Dutch healthcare technology manufacturer beat adjusted earnings estimates

** The company reported a 7.2% rise in its adjusted EBITA to €569 million ($636.71 million), while analysts were expecting €522 million

** Jefferies notes that the margin was surprisingly up in Q3, despite Philips previously guiding for margin erosion in the quarter

** Philips also reached an agreement in principle with the US Department of Justice over sleep and respiratory-care devices recall, and booked a €288 million provision in Q3

** KBC Securities welcomed the development, saying that most of the uncertainty related to the investigations has now been resolved, noting that the economic outflow related to these investigations was somewhat expected

** If gains hold, the stock is on track for its best day since February 2026, when it closed 11.8% higher

($1 = 0.8937 euros)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.